rs6501820

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_207346.3(TSEN54):​c.1122G>C​(p.Arg374Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.887 in 1,549,836 control chromosomes in the GnomAD database, including 616,313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 60900 hom., cov: 33)
Exomes 𝑓: 0.89 ( 555413 hom. )

Consequence

TSEN54
NM_207346.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.0780

Publications

19 publications found
Variant links:
Genes affected
TSEN54 (HGNC:27561): (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009]
TSEN54 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2A
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • pontocerebellar hypoplasia type 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
  • pontocerebellar hypoplasia type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 17-75522203-G-C is Benign according to our data. Variant chr17-75522203-G-C is described in ClinVar as Benign. ClinVar VariationId is 96670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.078 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.967 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN54NM_207346.3 linkc.1122G>C p.Arg374Arg synonymous_variant Exon 8 of 11 ENST00000333213.11 NP_997229.2 Q7Z6J9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN54ENST00000333213.11 linkc.1122G>C p.Arg374Arg synonymous_variant Exon 8 of 11 1 NM_207346.3 ENSP00000327487.6 Q7Z6J9-1

Frequencies

GnomAD3 genomes
AF:
0.888
AC:
135078
AN:
152078
Hom.:
60847
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.975
Gnomad AMI
AF:
0.925
Gnomad AMR
AF:
0.704
Gnomad ASJ
AF:
0.835
Gnomad EAS
AF:
0.550
Gnomad SAS
AF:
0.876
Gnomad FIN
AF:
0.885
Gnomad MID
AF:
0.927
Gnomad NFE
AF:
0.906
Gnomad OTH
AF:
0.878
GnomAD2 exomes
AF:
0.814
AC:
127526
AN:
156712
AF XY:
0.829
show subpopulations
Gnomad AFR exome
AF:
0.982
Gnomad AMR exome
AF:
0.544
Gnomad ASJ exome
AF:
0.819
Gnomad EAS exome
AF:
0.526
Gnomad FIN exome
AF:
0.886
Gnomad NFE exome
AF:
0.908
Gnomad OTH exome
AF:
0.844
GnomAD4 exome
AF:
0.887
AC:
1239748
AN:
1397640
Hom.:
555413
Cov.:
81
AF XY:
0.888
AC XY:
611569
AN XY:
688622
show subpopulations
African (AFR)
AF:
0.982
AC:
31006
AN:
31584
American (AMR)
AF:
0.563
AC:
20513
AN:
36414
Ashkenazi Jewish (ASJ)
AF:
0.823
AC:
20664
AN:
25112
East Asian (EAS)
AF:
0.513
AC:
18347
AN:
35746
South Asian (SAS)
AF:
0.891
AC:
70610
AN:
79274
European-Finnish (FIN)
AF:
0.887
AC:
42696
AN:
48156
Middle Eastern (MID)
AF:
0.927
AC:
5215
AN:
5628
European-Non Finnish (NFE)
AF:
0.910
AC:
980350
AN:
1077822
Other (OTH)
AF:
0.869
AC:
50347
AN:
57904
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
8113
16227
24340
32454
40567
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21056
42112
63168
84224
105280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.888
AC:
135185
AN:
152196
Hom.:
60900
Cov.:
33
AF XY:
0.882
AC XY:
65653
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.975
AC:
40532
AN:
41556
American (AMR)
AF:
0.703
AC:
10743
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.835
AC:
2898
AN:
3472
East Asian (EAS)
AF:
0.550
AC:
2833
AN:
5152
South Asian (SAS)
AF:
0.876
AC:
4225
AN:
4824
European-Finnish (FIN)
AF:
0.885
AC:
9382
AN:
10604
Middle Eastern (MID)
AF:
0.925
AC:
272
AN:
294
European-Non Finnish (NFE)
AF:
0.906
AC:
61605
AN:
67996
Other (OTH)
AF:
0.877
AC:
1851
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
721
1442
2163
2884
3605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.896
Hom.:
19813
Bravo
AF:
0.872
Asia WGS
AF:
0.762
AC:
2650
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Nov 12, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontocerebellar hypoplasia type 2A Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pontocerebellar hypoplasia type 5 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontocerebellar hypoplasia type 4 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
5.6
DANN
Benign
0.72
PhyloP100
0.078
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6501820; hg19: chr17-73518284; COSMIC: COSV51344477; COSMIC: COSV51344477; API